10-K: Jushi Holdings Inc. Reports Fiscal Year 2024 Results, Navigates Competitive Cannabis Market

Jushi Holdings Inc. announces its FY2024 financial results, highlighting strategic growth in a competitive cannabis market while managing regulatory and economic challenges.

Summary

• Jushi Holdings Inc., a vertically integrated multi-state cannabis operator, released its financial results for the fiscal year ended December 31, 2024.
• The company reported a net revenue of $257.5 million, a decrease of 4% compared to $269.4 million in the previous year.
• Retail revenue decreased by $11.4 million, primarily due to sales declines in Illinois, Massachusetts, Nevada, and Pennsylvania, partially offset by increases in Virginia and Ohio.
• Wholesale revenue decreased slightly by $0.5 million, with declines in Massachusetts, Nevada, and Pennsylvania offset by growth in Virginia.
• Gross profit increased to $118.3 million, with a gross profit margin of 46%, up from 43% in the prior year.
• Operating expenses decreased by 10% to $107.4 million, driven by lower impairment charges and share-based compensation expenses.
• The company reported a net loss of $48.8 million, an improvement from the $65.1 million loss in the previous year.
• Adjusted EBITDA increased by 13% to $46.2 million, driven by operating efficiencies and lower operating expenses.
• As of December 31, 2024, the company had $21.3 million in cash, cash equivalents, and restricted cash.
• The company operates 38 dispensaries across seven states and has cultivation and processing facilities in multiple states.

Sentiment

Score: 6

Explanation: The document presents a mixed picture. While there are improvements in gross profit margin and operating expense reduction, the decrease in revenue and net loss indicate ongoing challenges. The company's strategic focus and potential for future growth are positive, but regulatory and competitive risks remain significant.

Positives

• Gross profit margin improved to 46% from 43% due to efficiencies at cultivation and processing facilities.
• Operating expenses decreased by 10% due to lower impairment charges and share-based compensation.
• Adjusted EBITDA increased by 13% to $46.2 million.
• The company is in compliance with the laws of the states in which it operates and the related cannabis licensing frameworks.
• The company has implemented regular compliance reviews to ensure its subsidiaries and establishments to which it provides operational support are operating in conformance with applicable State and local cannabis rules and regulations.

Negatives

• Net revenue decreased by 4% to $257.5 million due to sales declines in key markets.
• The company reported a net loss of $48.8 million, although this is an improvement from the previous year.
• The company faces increasing competition and pricing pressures in the cannabis industry.
• The company is subject to risks related to growing an agricultural product.
• The company is highly dependent on certain key personnel.

Risks

• Cannabis remains illegal under U.S. federal law, posing a significant risk to the company.
• The regulation of cannabis in the U.S. is uncertain and subject to change.
• The company is constrained by law in its ability to market its products.
• Anti-Money Laundering Laws in the U.S. may limit access to funds from banks and other financial institutions.
• The company is subject to certain tax provisions that have a material adverse effect on its business, financial condition and results of operations.
• The company may not be able to adequately protect its intellectual property.
• The company's property is subject to risk of civil asset forfeiture.
• The company could be subject to criminal prosecution or civil liabilities under the Racketeer Influenced Corrupt Organizations Act (RICO).

Future Outlook

The company believes that its existing cash and cash equivalents and cash from operations will be sufficient to meet its working capital and capital expenditure needs for at least the next twelve months and may choose to take advantage of additional opportunistic capital raising or refinancing transactions at any time.

Industry Context

The cannabis industry is highly competitive with relatively high barriers to entry given the licensed nature of the cannabis industry. The company competes against other retail and vertical licensees across the various state markets in which it operates, including small local dispensaries and large multi-state operators (MSOs).

Comparison to Industry Standards

• The document mentions competition with larger MSOs in Massachusetts, Nevada, Ohio, Pennsylvania, and Virginia, which may have better access to public markets and more experienced management teams.
• The company seeks to minimize risks through accretive acquisitions, superior execution, and thoughtful location of retail and manufacturing sites.
• The document does not provide specific comparisons to industry benchmarks or comparable companies' financial results.

Legal Proceedings

• The company is involved in litigation relating to claims arising from the ordinary course of business, including the MJs Market Matter and the Pacific Collective Matter.

Related Party Transactions

• The document discloses related party transactions involving the CEO and a significant investor related to Second Lien Notes and Term Loans.

Stakeholder Impact

• The company's performance impacts shareholders, employees, customers, suppliers, and creditors.
• The company is committed to acting with respect toward its internal and external partners and expects its employees, directors, and third-party suppliers and contractors to respect the human rights of internal and external partners.

Next Steps

• The company plans to expand its network of cannabis retail locations in select markets.
• The company will continue the rollout of its flagship brands across its key operating markets.
• The company will continue to work closely with outside counsel and other compliance experts to further develop, enhance and improve its compliance and risk management and mitigation processes and procedures in furtherance of continued compliance with the complex regulatory frameworks of the states where the Company operates.

Key Dates

Keywords

cannabis, Jushi Holdings, financial results, multi-state operator, dispensaries, cultivation, processing, revenue, EBITDA, regulations, licenses